STAT+: A kidney disease showdown, and eye risk linked to GLP-1s
And more biotech news brought to you by The Readout.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning, happy Friday! Let’s get into the news.
Otsuka tops Vera Therapeutics in kidney disease study showdown
From STAT’s Adam Feuerstein: Another example of why biotech is a tough business.
